Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults ...

• Main Authors: Bjørndal, Bodil, Strand, Elin, Gjerde, Jennifer, Bohov, Pavol, Svardal, Asbjørn, Diehl, Bernd W., Innis, Sheila M., Berger, Alvin, Berge, Rolf K.
• Format: Text
• Language: English
• Published: BioMed Central 2015
• Subjects: Arctic
• Online Access: https://dx.doi.org/10.14288/1.0132566; https://doi.library.ubc.ca/10.14288/1.0132566

Background. Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (DHA)-rich fish oil mixture, with a DHA:eicosapentaenoic acid (EPA) ratio of about 3:1, which is also rich in choline. In this pilot study, we determined if MOPL30 could favorably affect plasma lipid parameters and glucose tolerance in healthy young adults. Methods Twenty female and one male adults, between 22 and 26 years of age, participated in the study. Participants took encapsulated MOPL30, 2.4 g/d EPA + DHA, for 14 days, and completed a three-day weighed food record before and during the capsule intake. Plasma lipids and their fatty acid (FA) composition, plasma and red blood cell (RBC) phosphatidylcholine (PC) FA composition, acylcarnitines, choline, betaine and insulin were measured before and after ...